Double-targeted knockdown of miR-21 and CXCR4 was performed in glioma cell lines (U87 and U251), and its effects on glioma malignant progression were evaluated in cells and xenograft mouse models. This evidence concerns the gene CXCR4 and central nervous system cancer.